Sentences with phrase «future funding uncertainties»

Sixty - six of the state's 67 school districts did not spend all of the Chapter 1 money that was coming to them, electing to carry over some money as a cushion against future funding uncertainties, confirmed Cecil G. Carlton, director of the state's bureau of compensatory education.

Caroline Wright, BESA director, said: «Our research shows a lot of future funding uncertainty, with 42 per cent of schools attributing this to the forthcoming election.

Not exact matches

Oscar, which offers health insurance policies that are easier to understand within a user - friendly app - based interface, has raised a reported $ 727 million in funding since 2013, though the company has failed to generate a profit and faces a murky future thanks to the uncertainty surrounding Obamacare.

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

As a report from the International Monetary Fund (IMF) observes, «Uncertainty about future exchange rates and GDP growth reduces flows into equities.»

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.

With just over a week to go before the budget deadline, Cuomo for the first time hinted that the spending plan might not be completed on time because of the uncertainty about future federal funding.

The groups say all the uncertainty over when the funds for supportive housing will finally be released is making it harder to plan for any future housing projects, while the number of homeless New Yorkers is growing.

«Reducing unnecessary spending allows the City to direct resources effectively and build larger reserves as New York City's economy shows signs of slowing and uncertainty remains around the future of federal funding,» wrote Riley Edwards, CBC research associate, in a blog post.

The battle for increased reimbursement will play out over the next 90 days as the budget is negotiated, and against the backdrop of a state - imposed Medicaid cap, uncertainty over the future of federal Medicaid funding and cries from long - term care facilities and home health care providers, which are also pleading for higher reimbursements.

Four million New Yorkers will have to re-enroll for their health insurance starting Nov. 1 amid uncertainty over the future of the federally funded program.

Because of uncertainty about the future, research leaders say, UK institutions that rely on EU funding are already seeing their staff dropped or demoted from planned collaborative EU grant applications, and top talent could already be leaving Britain.

Political and economic uncertainty fuels fears over the future of science funding and collaboration

Nevertheless, the uncertainty about the program's future drove away potential donors, thereby limiting the amount of funds available for scholarships.

There has never been a worse time for there to be uncertainty over how the training of future educational psychologists will be funded.

«At a time when students are increasingly hesitant about their prospects in the job market, and schools and universities face uncertainty when it comes to securing funding, there is a need for solid evidence to inform crucial decisions and shape future policies», Jane adds.

«With budgets already stretched, and uncertainty about future funding, ASCD is sensitive to the challenges school leaders face when making financial decisions for their staff and students,» said Deb Delisle, ASCD Executive Director and CEO.

However accounts say the «material uncertainty» of future funding may «cast significant doubt on the trust's ability to continue as a going concern».

The walkout happened in the face of uncertainty about the future of school funding, which the government claims to be protecting in «real terms».

But uncertainty over its future has prompted speculation it could be incorporated into the new national funding formula.

Chris Belfield, one of the report's authors, said the reform was always going to create «winners and losers» at a time of «severe pressure on school budgets», but said there was «significant uncertainty» about the future funding position for large numbers of schools

Both Wagner and Wedding aren't sure what the future holds for ACE and COOL because of funding uncertainties.

Retiring without sufficient funds can be significantly dangerous and detrimental especially as we face uncertainty over future social security benefits and medicare protection;

A steep yield curve generally means that inflation expectations are rising or there is great uncertainty of the future, as it implies that people are either (1) reluctant to buy longer term bonds, or (2) are are keeping their funds liquid because they feel uncertain about the future.

In this time of uncertainty surrounding the future of federal arts funding, the Wexner Center, alongside other distinguished arts organizations in Ohio and across our nation, stands as testament to the NEA's vital role in encouraging artistic excellence and enriching the cultural conversation in communities throughout the US and beyond.»

As the world reacts to the uncertainty of cryptocurrency offerings, such as initial coin offerings, initial token offerings and sales of securities of cryptocurrency investment funds, many startups in the community are having discussions on what the future of Canadian innovation in the cryptocurrency space looks like.

CHIP funding is even more urgent because of instability in health insurance markets, in part caused by uncertainty over the future of Obamacare.

Another factor clouding the future of farmland preservation is uncertainty about funding for, and the direction of, federal protection programs.

Such statements regarding future events and / or the future performance of the Fund are subject to certain risks and uncertainties that could cause actual events or the actual future results of Canopy South Financial, LLC to differ materially from such forward - looking statements.